Diaverum Saudi Arabia awarded JCI Gold Seal of Approval[®]
Diaverum, a leading global renal care service provider, is proud to announce that its Saudi Arabia operation has been accredited for the first time by the Joint Commission International (JCI) for its ambulatory care network. The world-renowned accreditation demonstrates the company’s excellence in renal care provision and organisation management in the country.
The JCI and its quality mark, Gold Seal of Approval®, have for more than 45 years formed a globally recognised benchmark that represents one of the most comprehensive evaluation processes in the healthcare industry. Its Ambulatory Care Accreditation Programme sets the standard and offers recognition to safe, high-quality patient care practices across a spectrum of freestanding ambulatory care facilities worldwide.
This accreditation is testament to the standards of excellence Diaverum has achieved since it began offering life enhancing care to patients with End-Stage Renal Disease (ESRD) in Saudi Arabia over eight years ago. The implementation of Diaverum’s integrated, patient-centric model, that delivers benchmark medical outcomes and patient satisfaction levels, both within the company’s global network of clinics as well as industry-wide, has been integral to meeting the JCI’s standards of performance.
Commenting on the significance of the JCI accreditation, Ziyad Kabli, Country Manager for Saudi Arabia and Regional Vice President for the Middle East region, said: “We receive the JCI accreditation with great pride. It’s a true testament to our one-of-a-kind, value-based care delivery approach that has been providing superior medical outcomes to our patients. Our vision at Diaverum is to transform renal services, empowering our patients to live fulfilling lives. This means we set the bar high, putting the patient first and very often, going beyond contractual requirements to offer the highest quality of care.”
Ali Shakir, Business Development Director at Diaverum, added that: “The world renowned JCI accreditation for ambulatory care networks enhances the sustainability of our Public Private Partnership (PPP) with the Ministry of Health of Saudi Arabia; enabling access to quality care across the Kingdom since 2013. This accreditation advocates for further developing healthcare models based on values and outcomes. This will inevitably strengthen our market position in the region as the renal care provider of choice for patients, national health services and healthcare professionals alike”.
Since Diaverum commenced operations in Saudi Arabia in 2013, it has made significant investments in its clinic infrastructure. It has also transferred medical and operational knowledge to develop both local and international talents through Diaverum’s d.ACADEMY programme, which in Saudi Arabia comprises a certified training centre located in Riyadh, providing continuous education in practice through physical and virtual training modules, with accreditation from the Saudi Commission for Health Specialties (SCFHS).
Nationwide, Diaverum Saudi Arabia provides holistic dialysis services, including among others the coordination of patients’ comorbidities through nutrition, pharmaceutical and social care, as well as vascular access surgeries and holiday dialysis.
Today, Diaverum provides care for more than 4,300 patients across 40 clinics in 33 cities and towns, making it the largest renal care provider in Saudi Arabia and the Middle East.
Ali Shakir
Business Development Director
ali.shakir@diaverum.com
+966 (0) 505 833 225
Bruno Pamplona Polizio
Director of Global Communications
bruno.polizio@diaverum.com
About Diaverum
Diaverum provides life enhancing renal care to patients with Chronic Kidney Disease (CKD), enabling them to live fulfilling lives. Diaverum is a leading global provider in renal care services, and we help some 40,000 patients with 6.2 million treatments annually. Our vision is to transform renal care, to deliver the highest quality of care for patients and reduce total cost of care for payers. Our focus is haemodialysis, but we offer a portfolio of treatments ranging from preventive care, peritoneal dialysis and home care to coordination of patients’ comorbidities, transplantation services and holiday dialysis. Diaverum employs around 14,000 people and operates 450 clinics in 24 countries globally. Diaverum has its head office in Malmö, Sweden.
